Customer Center

SSamyang Group News

Samyang Group News
Samyang Biopharmaceuticals Corp. Attends, ‘Arab Health 2018’ Print
Affiliates Samyang Biopharm Writer administrator Hits 4758 Date 2018.01.29

Samyang Biopharmaceuticals Corporation attended ‘Arab Health 2018’, the 43rd international healthcare exhibition held in Dubai from January 29 to February 1, 2018.


At this exhibition Samyang Biopharmaceuticals Corporation showcased its wound care products, highlighting the superiority of the suture products such as Trisorb, Neosorb, Monosorb, Monofast, and Antibacterial sutures, as well as ORC styptic products such as Surgi-Guard.


Samyang Biopharmaceuticals Corporation networked with over 30 overseas clients at the ‘Arab Health 2018’ and shared their thoughts on business for the year 2018.

이전 다음글 제목을 나타낸 표
Prev Yangyoung Foundation and Sudang Foundation Hold 2018 Scholarship Awards Ceremony 2018.02.20
Next Samyang Corporation concludes Technology Transfer Agreement of Oxime Photoinitiator with the Korea Research Institute of Chemical Technology 2018.01.23